| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.89e-05 | 188 | 208 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 8.67e-05 | 23 | 208 | 4 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.43e-04 | 26 | 208 | 4 | GO:0000295 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 1.73e-04 | 11 | 208 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 2.21e-04 | 29 | 208 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 3.69e-04 | 33 | 208 | 4 | GO:0015215 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 3.73e-04 | 14 | 208 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GP6 ADGRG5 PDGFRB GPR182 ADGRB2 OR14C36 CHRM3 OR1L1 UNC5A OR52B4 PTPRB NRXN1 OR1P1 FGFR1 NPBWR1 OXER1 TMEM116 GRM3 CR1L CR2 OR10D3 FSHR ROBO1 SMO IL1RL1 LGR6 CALCRL PALLD | 3.93e-04 | 1353 | 208 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | adrenomedullin receptor activity | 6.39e-04 | 4 | 208 | 2 | GO:0001605 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 6.80e-04 | 17 | 208 | 3 | GO:0005161 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 7.07e-04 | 39 | 208 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 7.07e-04 | 39 | 208 | 4 | GO:0015605 | |
| GeneOntologyMolecularFunction | cupric ion binding | 1.06e-03 | 5 | 208 | 2 | GO:1903135 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 1.06e-03 | 5 | 208 | 2 | GO:0005471 | |
| GeneOntologyBiologicalProcess | axon guidance | PRTG RELN UNC5A NEO1 NRXN1 GLI3 SEMA6C ANK3 DVL1 LMTK2 LAMB3 LAMC1 ROBO1 SMO LGR6 PALLD | 3.27e-08 | 285 | 207 | 16 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | PRTG RELN UNC5A NEO1 NRXN1 GLI3 SEMA6C ANK3 DVL1 LMTK2 LAMB3 LAMC1 ROBO1 SMO LGR6 PALLD | 3.43e-08 | 286 | 207 | 16 | GO:0097485 |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 6.68e-07 | 8 | 207 | 4 | GO:0045959 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 ARHGAP32 PRTG RELN USP9X CUL7 AURKA UNC5A NEO1 F11R NRXN1 PTPRJ GLI3 AHR PHIP CAP1 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 REG1A TECTA CDH19 ROBO1 SMO LGR6 RAPGEF2 PALLD | 1.10e-06 | 1194 | 207 | 31 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 ARHGAP32 PRTG RELN USP9X CUL7 AURKA UNC5A NEO1 NRXN1 GLI3 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 REG1A ROBO1 SMO LGR6 RAPGEF2 PALLD | 1.86e-06 | 802 | 207 | 24 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 ARHGAP32 PRTG RELN USP9X CUL7 UNC5A NEO1 NRXN1 GLI3 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 TECTA ROBO1 SMO LGR6 RAPGEF2 PALLD | 1.97e-06 | 748 | 207 | 23 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 1.97e-06 | 10 | 207 | 4 | GO:0030450 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 ARHGAP32 PRTG RELN USP9X CUL7 AURKA UNC5A NEO1 NRXN1 GLI3 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 REG1A ROBO1 SMO LGR6 RAPGEF2 PALLD | 2.67e-06 | 819 | 207 | 24 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 ARHGAP32 PRTG RELN USP9X CUL7 AURKA UNC5A NEO1 NRXN1 GLI3 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 REG1A ROBO1 SMO LGR6 RAPGEF2 PALLD | 3.09e-06 | 826 | 207 | 24 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.58e-06 | 12 | 207 | 4 | GO:0002924 | |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGAP32 PRTG RELN USP9X UNC5A NEO1 NRXN1 GLI3 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 ROBO1 SMO LGR6 PALLD | 4.67e-06 | 566 | 207 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 9.12e-06 | 14 | 207 | 4 | GO:0045916 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | INTU ACD MCM8 USP9X ATG13 OBSCN TMCO6 AURKA GLI3 AHR PHIP HSP90AA1 KIF2C KPNB1 COG7 DVL1 POM121L2 CEP192 MON1A HUWE1 ATP13A2 CEP63 HACL1 SMO VPS28 TP53 FBXW7 | 1.39e-05 | 1091 | 207 | 27 | GO:0033365 |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.63e-05 | 16 | 207 | 4 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.63e-05 | 16 | 207 | 4 | GO:0002713 | |
| GeneOntologyBiologicalProcess | axon development | ARHGAP32 PRTG RELN USP9X UNC5A NEO1 NRXN1 GLI3 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 ROBO1 SMO LGR6 PALLD | 2.72e-05 | 642 | 207 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration | 3.38e-05 | 7 | 207 | 3 | GO:0021800 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 3.39e-05 | 19 | 207 | 4 | GO:0002921 | |
| GeneOntologyBiologicalProcess | protein stabilization | MCM8 USP9X HSP90AA1 HSP90AB3P COG7 DVL1 CEP63 NCOR1 SMO TP53 FBXW7 | 3.65e-05 | 243 | 207 | 11 | GO:0050821 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 4.01e-05 | 63 | 207 | 6 | GO:0033120 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.23e-05 | 66 | 207 | 6 | GO:0002823 | |
| GeneOntologyBiologicalProcess | spinal cord patterning | 6.26e-05 | 22 | 207 | 4 | GO:0021511 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 6.26e-05 | 22 | 207 | 4 | GO:0002923 | |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 RELN USP9X ADGRB2 MDGA2 LRRTM3 NRXN1 FGFR1 CAP1 KIF2C UNC13B ANK3 DVL1 SEZ6L2 ROBO1 IGSF9B RAPGEF2 PALLD PDZRN3 | 6.50e-05 | 685 | 207 | 19 | GO:0050808 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | ACD USP9X ATG13 TMCO6 GLI3 PHIP HSP90AA1 KPNB1 POM121L2 MON1A HUWE1 HACL1 SMO VPS28 TP53 FBXW7 | 6.80e-05 | 515 | 207 | 16 | GO:0072594 |
| GeneOntologyBiologicalProcess | basement membrane organization | 6.85e-05 | 43 | 207 | 5 | GO:0071711 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 7.66e-05 | 44 | 207 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 7.91e-05 | 71 | 207 | 6 | GO:0002820 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 ARHGAP32 PRTG RELN SETX USP9X CUL7 AURKA UNC5A NEO1 NRXN1 GLI3 FGFR1 SEMA6C ARHGEF28 ANK3 DVL1 LMTK2 LAMB3 LAMC1 REG1A TECTA FSHR ROBO1 SMO LGR6 RAPGEF2 PALLD | 9.09e-05 | 1285 | 207 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of hepatic stellate cell activation | 1.13e-04 | 10 | 207 | 3 | GO:2000491 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 RELN USP9X ADGRB2 MDGA2 LRRTM3 F11R NRXN1 PTPRJ FGFR1 CAP1 KIF2C UNC13B ANK3 DVL1 LAMC1 CDH19 SEZ6L2 ROBO1 IGSF9B RAPGEF2 PALLD PDZRN3 | 1.27e-04 | 974 | 207 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.44e-04 | 27 | 207 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 ARHGAP32 PRTG RELN SETX USP9X CUL7 AURKA UNC5A NEO1 NRXN1 GLI3 FGFR1 SEMA6C ARHGEF28 ANK3 HCN1 DVL1 LMTK2 LAMB3 LAMC1 REG1A TECTA TFAP2A FSHR ROBO1 SMO LGR6 RAPGEF2 PALLD | 1.47e-04 | 1463 | 207 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.91e-04 | 118 | 207 | 7 | GO:0001570 | |
| GeneOntologyBiologicalProcess | ADP transport | 2.05e-04 | 12 | 207 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | postnatal olfactory bulb interneuron migration | 2.99e-04 | 3 | 207 | 2 | GO:0021827 | |
| GeneOntologyBiologicalProcess | cerebral cortex tangential migration using cell-cell interactions | 2.99e-04 | 3 | 207 | 2 | GO:0021823 | |
| GeneOntologyBiologicalProcess | substrate-dependent cerebral cortex tangential migration | 2.99e-04 | 3 | 207 | 2 | GO:0021825 | |
| GeneOntologyBiologicalProcess | positive regulation of acinar cell proliferation | 2.99e-04 | 3 | 207 | 2 | GO:1904699 | |
| GeneOntologyBiologicalProcess | regulation of hepatic stellate cell activation | 3.34e-04 | 14 | 207 | 3 | GO:2000489 | |
| GeneOntologyBiologicalProcess | regulation of protein stability | MCM8 USP9X AURKA HSP90AA1 HSP90AB3P COG7 DVL1 CEP63 NCOR1 SMO TP53 FBXW7 | 3.61e-04 | 368 | 207 | 12 | GO:0031647 |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 3.95e-04 | 62 | 207 | 5 | GO:0002455 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 RELN LRRTM3 FCGBP AEBP1 HSP90AA1 FRAS1 VWF COL20A1 ECM2 LAMB3 LAMC1 REG1A MUC5B TECTA ADAMTS12 HMCN1 LGR6 CTSD MUC2 | 1.46e-05 | 656 | 214 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 RELN LRRTM3 FCGBP AEBP1 HSP90AA1 FRAS1 VWF COL20A1 ECM2 LAMB3 LAMC1 REG1A MUC5B TECTA ADAMTS12 HMCN1 LGR6 CTSD MUC2 | 1.52e-05 | 658 | 214 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | axon | IGSF8 MYC TANC2 PRTG RELN SETX USP9X CHRM3 AURKA NEO1 NRXN1 HSP90AA1 UNC13B ANK3 HCN1 DVL1 LMTK2 REG1A GRM3 SLC1A2 ROBO1 SMO PALLD | 4.57e-05 | 891 | 214 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | axonal growth cone | 9.39e-05 | 45 | 214 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | growth cone | 2.27e-04 | 245 | 214 | 10 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.93e-04 | 253 | 214 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | distal axon | SETX USP9X CHRM3 NEO1 NRXN1 HSP90AA1 UNC13B HCN1 DVL1 LMTK2 REG1A SMO PALLD | 5.74e-04 | 435 | 214 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | cell body | RELN SNPH RRM1 AURKA UNC5A NEO1 NRXN1 C4BPA HSP90AA1 HCN1 DVL1 LMTK2 REG1A SEZ6L2 ATP13A2 SLC1A2 ROBO1 SMO IGSF9B RAPGEF2 PALLD | 5.89e-04 | 929 | 214 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 ARHGAP32 RELN SNPH RRM1 CHRM3 AURKA UNC5A NEO1 NRXN1 HSP90AA1 ANK3 HCN1 DVL1 LMTK2 REG1A GRM3 SEZ6L2 ATP13A2 SLC1A2 ROBO1 SMO IGSF9B RAPGEF2 PALLD | 8.21e-04 | 1228 | 214 | 25 | GO:0036477 |
| GeneOntologyCellularComponent | neuronal cell body | RELN SNPH RRM1 AURKA UNC5A NEO1 NRXN1 HSP90AA1 HCN1 DVL1 LMTK2 REG1A SEZ6L2 ATP13A2 ROBO1 SMO IGSF9B RAPGEF2 PALLD | 9.97e-04 | 835 | 214 | 19 | GO:0043025 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THSD4 RELN AEBP1 HSP90AA1 FRAS1 VWF COL20A1 ECM2 LAMB3 LAMC1 REG1A HMCN1 CTSD MUC2 | 1.18e-03 | 530 | 214 | 14 | GO:0062023 |
| Domain | VWC_out | 7.04e-10 | 19 | 202 | 7 | SM00215 | |
| Domain | Ig_I-set | PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 F11R FGFR1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD | 2.41e-09 | 190 | 202 | 15 | IPR013098 |
| Domain | I-set | PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 F11R FGFR1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD | 2.41e-09 | 190 | 202 | 15 | PF07679 |
| Domain | IGc2 | GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 NEO1 F11R FGFR1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 | 5.95e-09 | 235 | 202 | 16 | SM00408 |
| Domain | Ig_sub2 | GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 NEO1 F11R FGFR1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 | 5.95e-09 | 235 | 202 | 16 | IPR003598 |
| Domain | VWC | 6.03e-09 | 38 | 202 | 8 | SM00214 | |
| Domain | IG | IGSF8 GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 F11R IZUMO1 FGFR1 PILRA HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 TREML2 | 6.42e-09 | 421 | 202 | 21 | SM00409 |
| Domain | Ig_sub | IGSF8 GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 F11R IZUMO1 FGFR1 PILRA HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 TREML2 | 6.42e-09 | 421 | 202 | 21 | IPR003599 |
| Domain | - | IGSF8 GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 NXPE1 UNC5A NEO1 PTPRB F11R PTPRJ IZUMO1 FGFR1 PILRA COL20A1 FANK1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 TREML2 | 1.40e-08 | 663 | 202 | 26 | 2.60.40.10 |
| Domain | VWF_dom | 1.40e-08 | 42 | 202 | 8 | IPR001007 | |
| Domain | Ig-like_fold | IGSF8 GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 NXPE1 UNC5A NEO1 PTPRB F11R PTPRJ IZUMO1 FGFR1 PILRA COL20A1 FANK1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 TREML2 | 4.94e-08 | 706 | 202 | 26 | IPR013783 |
| Domain | IG_LIKE | IGSF8 GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 F11R IZUMO1 FGFR1 PILRA HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 TREML2 | 9.04e-08 | 491 | 202 | 21 | PS50835 |
| Domain | C8 | 1.05e-07 | 12 | 202 | 5 | PF08742 | |
| Domain | TIL | 1.05e-07 | 12 | 202 | 5 | PF01826 | |
| Domain | Ig-like_dom | IGSF8 GP6 PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 F11R IZUMO1 FGFR1 PILRA HMCN1 ROBO1 IGSF9B IL1RL1 PALLD GPA33 TREML2 | 1.35e-07 | 503 | 202 | 21 | IPR007110 |
| Domain | VWFC_2 | 1.48e-07 | 38 | 202 | 7 | PS50184 | |
| Domain | Unchr_dom_Cys-rich | 1.69e-07 | 13 | 202 | 5 | IPR014853 | |
| Domain | C8 | 1.69e-07 | 13 | 202 | 5 | SM00832 | |
| Domain | TIL_dom | 2.60e-07 | 14 | 202 | 5 | IPR002919 | |
| Domain | VWF_type-D | 5.58e-07 | 16 | 202 | 5 | IPR001846 | |
| Domain | VWFD | 5.58e-07 | 16 | 202 | 5 | PS51233 | |
| Domain | VWD | 5.58e-07 | 16 | 202 | 5 | SM00216 | |
| Domain | VWD | 5.58e-07 | 16 | 202 | 5 | PF00094 | |
| Domain | VWFC_1 | 2.21e-06 | 36 | 202 | 6 | PS01208 | |
| Domain | FN3 | PRTG IGFN1 OBSCN MDGA2 NEO1 PTPRB PTPRJ COL20A1 FANK1 ROBO1 IGSF9B | 1.13e-05 | 199 | 202 | 11 | PS50853 |
| Domain | VWC | 1.13e-05 | 28 | 202 | 5 | PF00093 | |
| Domain | IGv | 1.66e-05 | 75 | 202 | 7 | SM00406 | |
| Domain | FN3_dom | PRTG IGFN1 OBSCN MDGA2 NEO1 PTPRB PTPRJ COL20A1 FANK1 ROBO1 IGSF9B | 1.78e-05 | 209 | 202 | 11 | IPR003961 |
| Domain | Sushi | 2.00e-05 | 52 | 202 | 6 | PF00084 | |
| Domain | CCP | 2.49e-05 | 54 | 202 | 6 | SM00032 | |
| Domain | SUSHI | 3.08e-05 | 56 | 202 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.41e-05 | 57 | 202 | 6 | IPR000436 | |
| Domain | FN3 | PRTG IGFN1 OBSCN NEO1 PTPRB PTPRJ COL20A1 FANK1 ROBO1 IGSF9B | 3.44e-05 | 185 | 202 | 10 | SM00060 |
| Domain | Ig_V-set | IGSF8 VSIG2 OBSCN F11R PILRA HMCN1 ROBO1 IGSF9B GPA33 TREML2 | 6.36e-05 | 199 | 202 | 10 | IPR013106 |
| Domain | RBM1CTR | 6.71e-05 | 8 | 202 | 3 | PF08081 | |
| Domain | RBM1CTR | 6.71e-05 | 8 | 202 | 3 | IPR012604 | |
| Domain | fn3 | 6.88e-05 | 162 | 202 | 9 | PF00041 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.65e-04 | 53 | 202 | 5 | IPR011047 | |
| Domain | PMG | 3.29e-04 | 13 | 202 | 3 | PF05287 | |
| Domain | KRTAP_PMG | 3.29e-04 | 13 | 202 | 3 | IPR007951 | |
| Domain | TILa_dom | 3.47e-04 | 3 | 202 | 2 | IPR025615 | |
| Domain | TILa | 3.47e-04 | 3 | 202 | 2 | PF12714 | |
| Domain | TSP_1 | 5.95e-04 | 63 | 202 | 5 | PF00090 | |
| Domain | TSP1 | 6.87e-04 | 65 | 202 | 5 | SM00209 | |
| Domain | TSP1_rpt | 6.87e-04 | 65 | 202 | 5 | IPR000884 | |
| Domain | TSP1 | 6.87e-04 | 65 | 202 | 5 | PS50092 | |
| Domain | CTCK_1 | 9.02e-04 | 18 | 202 | 3 | PS01185 | |
| Domain | ig | 1.11e-03 | 190 | 202 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.11e-03 | 190 | 202 | 8 | IPR013151 | |
| Domain | TF_AP2 | 1.14e-03 | 5 | 202 | 2 | IPR004979 | |
| Domain | TF_AP2_C | 1.14e-03 | 5 | 202 | 2 | IPR013854 | |
| Domain | TF_AP-2 | 1.14e-03 | 5 | 202 | 2 | PF03299 | |
| Domain | CT | 1.65e-03 | 22 | 202 | 3 | SM00041 | |
| Domain | Gphrmn_rcpt_fam | 1.70e-03 | 6 | 202 | 2 | IPR002131 | |
| Domain | WxxW_domain | 1.70e-03 | 6 | 202 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.70e-03 | 6 | 202 | 2 | PF13330 | |
| Domain | Cys_knot_C | 2.41e-03 | 25 | 202 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.41e-03 | 25 | 202 | 3 | PS01225 | |
| Pubmed | 4.99e-08 | 7 | 216 | 4 | 8269511 | ||
| Pubmed | FBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping. | 9.93e-08 | 8 | 216 | 4 | 33086033 | |
| Pubmed | TANC2 ARHGAP32 USP9X ADGRB2 CCDC177 NRXN1 ARHGAP21 HSP90AA1 KIF2C KPNB1 DMXL2 ANK3 HCN1 ARHGEF12 HUWE1 GRM3 SLC1A2 NCOR1 PELP1 SPHKAP RAPGEF2 DCAF7 | 1.78e-07 | 963 | 216 | 22 | 28671696 | |
| Pubmed | MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. | 2.36e-07 | 3 | 216 | 3 | 24053468 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 32678161 | ||
| Pubmed | Secretagogue-induced pancreatitis in mice devoid of chymotrypsin. | 2.36e-07 | 3 | 216 | 3 | 38981616 | |
| Pubmed | 2.95e-07 | 10 | 216 | 4 | 9384609 | ||
| Pubmed | Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. | 4.61e-07 | 11 | 216 | 4 | 31570706 | |
| Pubmed | 6.89e-07 | 12 | 216 | 4 | 9598316 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 25533335 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 11297531 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 27213815 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 17984302 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 15370542 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 22754359 | ||
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 1.87e-06 | 15 | 216 | 4 | 14762062 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ARHGAP32 SETX ATG13 NADK ARHGAP21 KIF2C DYRK2 ARHGEF28 LMTK2 LAMC1 CEP192 PLEKHA2 CRYBG3 MAPK4 RAPGEF2 PALLD TP53 DCAF7 | 2.12e-06 | 861 | 216 | 19 | 36931259 |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 15265983 | ||
| Pubmed | Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer. | 2.34e-06 | 5 | 216 | 3 | 28209614 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 2.34e-06 | 5 | 216 | 3 | 8817321 | |
| Pubmed | Genetic and biochemical characterization of a new chymotrypsin isozyme of the house mouse, CTRA-1. | 2.34e-06 | 5 | 216 | 3 | 1820020 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 2.34e-06 | 5 | 216 | 3 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 2.34e-06 | 5 | 216 | 3 | 19737860 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 4.14e-06 | 18 | 216 | 4 | 12023983 | |
| Pubmed | 4.14e-06 | 18 | 216 | 4 | 11311202 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 19330026 | ||
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 4.66e-06 | 6 | 216 | 3 | 12356914 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 9499427 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 15051956 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 19110483 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 4.66e-06 | 6 | 216 | 3 | 18492746 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 27798604 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 18239052 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 15184870 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 OBSCN ADGRB2 TMCO6 NADK WDR90 FGFR1 ARHGAP21 UNC13B SEMA6C FRAS1 BICRA DVL1 LMTK2 LAMB3 CEP192 HUWE1 LARS2 ATP13A2 NCOR1 INTS5 | 6.23e-06 | 1105 | 216 | 21 | 35748872 |
| Pubmed | 7.97e-06 | 21 | 216 | 4 | 20081193 | ||
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 23699408 | ||
| Pubmed | Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. | 8.12e-06 | 7 | 216 | 3 | 18625840 | |
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 8.12e-06 | 7 | 216 | 3 | 8875892 | |
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 8.12e-06 | 7 | 216 | 3 | 10377282 | |
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 17001072 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ADGRG5 ERN1 USP9X CUL7 AURKA DHPS FGFR1 DYRK2 KPNB1 MOK AFF3 LAMC1 HUWE1 MAPK4 TP53 DCAF7 | 8.24e-06 | 695 | 216 | 16 | 23602568 |
| Pubmed | TANC2 ARHGAP32 USP9X ADGRB2 SNRK NEO1 NRXN1 SVOP CAP1 HSP90AA1 DMXL2 ANK3 HCN1 DVL1 LMTK2 HUWE1 FAM171B NFS1 SLC1A2 SPHKAP CRYBG3 | 9.84e-06 | 1139 | 216 | 21 | 36417873 | |
| Pubmed | ARHGAP32 USP9X TMEM165 RRM1 AURKA ARHGAP21 CAP1 HSP90AA1 KIF2C KPNB1 ANK3 ARHGEF12 TMPO ROBO1 CRYBG3 PALLD | 1.04e-05 | 708 | 216 | 16 | 39231216 | |
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 7479793 | ||
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 1.29e-05 | 8 | 216 | 3 | 2564419 | |
| Pubmed | THSD4 ADGRG5 TCTN3 ABHD15 VSIG2 MDGA2 LRRTM3 ARID5A F11R SUSD4 COG7 CDH19 SEZ6L2 ADAMTS12 FANK1 IGSF9B LGR6 CSMD1 TREML2 | 1.43e-05 | 985 | 216 | 19 | 12975309 | |
| Pubmed | FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development. | 1.65e-05 | 25 | 216 | 4 | 18625063 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MYC ARHGAP32 AEBP1 WDR90 KPNB1 ANK3 BICRA NBPF20 NCOR1 SETBP1 IGSF9B TP53 | 1.79e-05 | 430 | 216 | 12 | 35044719 |
| Pubmed | CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy. | 1.93e-05 | 9 | 216 | 3 | 29593330 | |
| Pubmed | A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis. | 1.99e-05 | 53 | 216 | 5 | 38466355 | |
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 10512189 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 10601091 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 33775822 | ||
| Pubmed | 3.00e-05 | 251 | 216 | 9 | 27507650 | ||
| Pubmed | 3.36e-05 | 59 | 216 | 5 | 11279525 | ||
| Pubmed | ARHGAP32 USP9X CUL7 PTPRB PTPRJ DHPS HSP90AA1 KPNB1 ANK3 LMTK2 CEP192 HUWE1 FAM171B TFAP2A NCOR1 TMPO ROBO1 CRYBG3 FBXW7 | 3.37e-05 | 1049 | 216 | 19 | 27880917 | |
| Pubmed | 3.61e-05 | 257 | 216 | 9 | 16335952 | ||
| Pubmed | 3.76e-05 | 11 | 216 | 3 | 16396903 | ||
| Pubmed | A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies. | 3.84e-05 | 2 | 216 | 2 | 38565249 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 21658391 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20372800 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 31276978 | ||
| Pubmed | Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. | 3.84e-05 | 2 | 216 | 2 | 14724288 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 21298377 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 8091232 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 39225558 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 25051961 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 15613472 | ||
| Pubmed | Induction of cullin 7 by DNA damage attenuates p53 function. | 3.84e-05 | 2 | 216 | 2 | 17586686 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 38408587 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 10557093 | ||
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 3.84e-05 | 2 | 216 | 2 | 8186414 | |
| Pubmed | Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration. | 3.84e-05 | 2 | 216 | 2 | 25986072 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 36827370 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 25878193 | ||
| Pubmed | Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. | 3.84e-05 | 2 | 216 | 2 | 16094360 | |
| Pubmed | Phosphorylation and hsp90 binding mediate heat shock stabilization of p53. | 3.84e-05 | 2 | 216 | 2 | 12427754 | |
| Pubmed | The Ah receptor is a sensitive target of geldanamycin-induced protein turnover. | 3.84e-05 | 2 | 216 | 2 | 9390191 | |
| Pubmed | Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. | 3.84e-05 | 2 | 216 | 2 | 7534899 | |
| Pubmed | Aurora-A interacts with AP-2α and down regulates its transcription activity. | 3.84e-05 | 2 | 216 | 2 | 21829699 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 25964345 | ||
| Pubmed | The involvement of Aurora-A and p53 in oxaliplatin-resistant colon cancer cells. | 3.84e-05 | 2 | 216 | 2 | 36976911 | |
| Pubmed | Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. | 3.84e-05 | 2 | 216 | 2 | 23518350 | |
| Pubmed | Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. | 3.84e-05 | 2 | 216 | 2 | 23518349 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 28498285 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 27376742 | ||
| Pubmed | Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice. | 3.84e-05 | 2 | 216 | 2 | 26518543 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 31990416 | ||
| Pubmed | Loss of the aryl hydrocarbon receptor increases tumorigenesis in p53-deficient mice. | 3.84e-05 | 2 | 216 | 2 | 35926564 | |
| Pubmed | Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. | 3.84e-05 | 2 | 216 | 2 | 10962037 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 32460012 | ||
| Pubmed | A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. | 3.84e-05 | 2 | 216 | 2 | 15498494 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20064835 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 25162227 | ||
| Pubmed | Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis. | 3.84e-05 | 2 | 216 | 2 | 20145032 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 36355424 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 34528662 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 34193438 | ||
| Interaction | TFAP2B interactions | 3.77e-06 | 24 | 205 | 5 | int:TFAP2B | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PRTG IGFN1 VSIG2 PDGFRB OBSCN MDGA2 UNC5A NEO1 FGFR1 HMCN1 ROBO1 IGSF9B IL1RL1 PALLD | 5.35e-11 | 161 | 147 | 14 | 593 |
| GeneFamily | Fibronectin type III domain containing | PRTG IGFN1 OBSCN NEO1 PTPRB PTPRJ COL20A1 FANK1 ROBO1 IGSF9B | 7.46e-07 | 160 | 147 | 10 | 555 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.73e-06 | 57 | 147 | 6 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing | 1.83e-04 | 193 | 147 | 8 | 594 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.77e-04 | 163 | 147 | 7 | 590 | |
| GeneFamily | CD molecules|Mucins | 6.29e-04 | 21 | 147 | 3 | 648 | |
| GeneFamily | PDZ domain containing | 1.53e-03 | 152 | 147 | 6 | 1220 | |
| GeneFamily | Complement system|Sushi domain containing | 3.09e-03 | 36 | 147 | 3 | 492 | |
| GeneFamily | Laminin subunits | 4.11e-03 | 12 | 147 | 2 | 626 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.17e-03 | 40 | 147 | 3 | 321 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THSD4 RELN NELL1 AEBP1 C4BPA VWA5B1 FRAS1 VWF ECM2 LAMB3 LAMC1 TECTA HMCN1 | 5.90e-09 | 191 | 212 | 13 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 RELN NELL1 AEBP1 C4BPA VWA5B1 FRAS1 VWF COL20A1 ECM2 LAMB3 LAMC1 TECTA HMCN1 | 4.83e-08 | 270 | 212 | 14 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THSD4 RELN NELL1 AEBP1 VWA5B1 FRAS1 VWF ECM2 LAMB3 LAMC1 TECTA HMCN1 | 7.42e-08 | 196 | 212 | 12 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 RELN NELL1 AEBP1 VWA5B1 FRAS1 VWF COL20A1 ECM2 LAMB3 LAMC1 TECTA HMCN1 | 4.24e-07 | 275 | 212 | 13 | M5884 |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | THSD4 TMEM165 AIG1 SUSD4 TMEM116 SGPP2 C16orf46 NCOR1 PLEKHA2 RAPGEF2 | 1.73e-05 | 227 | 212 | 10 | M18441 |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 3.10e-05 | 45 | 212 | 5 | MM763 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 RELN IGFN1 MDGA2 CCDC85A NELL1 F11R NRXN1 NIPA1 SVOP DYRK2 ANK3 AFF3 ARHGEF12 PCDHA7 FAM171B GRM3 SEZ6L2 SLC1A2 ROBO1 IGSF9B CSMD1 MUC2 | 3.46e-05 | 1106 | 212 | 23 | M39071 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP | 3.88e-05 | 200 | 212 | 9 | M5698 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | MYC PRPS2 THSD4 EME1 PRTG MDGA2 RRM1 MEOX2 NELL1 PTPRJ GLI3 FGFR1 ARHGEF12 LAMC1 CEP192 TFAP2A HMCN1 SETBP1 ROBO1 GREB1 CRYBG3 BBS12 | 2.70e-06 | 749 | 201 | 22 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | MYC PRTG PSMD5 MDGA2 MEOX2 NELL1 PTPRJ FGFR1 ADAMTS12 HMCN1 CALCRL BBS12 | 2.52e-05 | 294 | 201 | 12 | gudmap_kidney_P0_CapMes_Crym_500 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGAP32 NEO1 NRXN1 NIPA1 SLC25A23 FAM171B GRM3 CDH19 LARS2 SEZ6L2 SLC1A2 | 3.12e-09 | 196 | 214 | 11 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | PDGFRB MEOX2 AEBP1 GLI3 LAMC1 ADAMTS12 HMCN1 SETBP1 ROBO1 PALLD PDZRN3 | 3.29e-09 | 197 | 214 | 11 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | PDGFRB MEOX2 AEBP1 GLI3 FRAS1 LAMC1 ADAMTS12 HMCN1 SETBP1 ROBO1 PDZRN3 | 3.47e-09 | 198 | 214 | 11 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-08 | 170 | 214 | 10 | 9bea81031cdfe45e8cddac3a3afd9ca6c331c45a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-08 | 170 | 214 | 10 | 2c5a1469e5743870e96e6c2cc92f0c5096b79f51 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-08 | 184 | 214 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-08 | 184 | 214 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-08 | 184 | 214 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | THSD4 OBSCN LRRTM3 ANK3 ARHGEF12 MAPK4 PALLD GPA33 PDZRN3 FBXW7 | 2.88e-08 | 189 | 214 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | PDGFRB MEOX2 AEBP1 LAMC1 ADAMTS12 HMCN1 SETBP1 ROBO1 PALLD PDZRN3 | 3.87e-08 | 195 | 214 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | PDGFRB MEOX2 AEBP1 LAMC1 ADAMTS12 HMCN1 SETBP1 ROBO1 GREB1 PDZRN3 | 4.47e-08 | 198 | 214 | 10 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDGFRB MEOX2 AEBP1 GLI3 LAMC1 ADAMTS12 HMCN1 SETBP1 ROBO1 PDZRN3 | 4.47e-08 | 198 | 214 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PDGFRB MEOX2 AEBP1 LAMC1 ADAMTS12 HMCN1 SETBP1 ROBO1 PALLD PDZRN3 | 4.47e-08 | 198 | 214 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-07 | 171 | 214 | 9 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.02e-07 | 177 | 214 | 9 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-07 | 181 | 214 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.55e-07 | 182 | 214 | 9 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.93e-07 | 185 | 214 | 9 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.21e-07 | 187 | 214 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.67e-07 | 190 | 214 | 9 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.67e-07 | 190 | 214 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.84e-07 | 191 | 214 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-07 | 192 | 214 | 9 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-07 | 192 | 214 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.01e-07 | 192 | 214 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.19e-07 | 193 | 214 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.38e-07 | 194 | 214 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.57e-07 | 195 | 214 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.57e-07 | 195 | 214 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.77e-07 | 196 | 214 | 9 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 4.77e-07 | 196 | 214 | 9 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.77e-07 | 196 | 214 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.77e-07 | 196 | 214 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.98e-07 | 197 | 214 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.98e-07 | 197 | 214 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.98e-07 | 197 | 214 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 198 | 214 | 9 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-07 | 198 | 214 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.42e-07 | 199 | 214 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-07 | 199 | 214 | 9 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.42e-07 | 199 | 214 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.65e-07 | 200 | 214 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.65e-07 | 200 | 214 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | THSD4 ARHGAP32 CHRM3 PTPRJ ARHGEF28 ANK3 MUC16 MUC5B ITPRID1 | 5.65e-07 | 200 | 214 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.65e-07 | 200 | 214 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.65e-07 | 200 | 214 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-07 | 151 | 214 | 8 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-07 | 151 | 214 | 8 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-07 | 151 | 214 | 8 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-07 | 155 | 214 | 8 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-06 | 163 | 214 | 8 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-06 | 163 | 214 | 8 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-06 | 164 | 214 | 8 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.52e-06 | 167 | 214 | 8 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-06 | 168 | 214 | 8 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-06 | 168 | 214 | 8 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-06 | 168 | 214 | 8 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 169 | 214 | 8 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 169 | 214 | 8 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-06 | 174 | 214 | 8 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.07e-06 | 174 | 214 | 8 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.10e-06 | 122 | 214 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-06 | 175 | 214 | 8 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 177 | 214 | 8 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 177 | 214 | 8 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 177 | 214 | 8 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-06 | 177 | 214 | 8 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-06 | 177 | 214 | 8 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.45e-06 | 178 | 214 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | wk_08-11-Epithelial-PNS-Late_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.45e-06 | 178 | 214 | 8 | a7301c0bba03d10feacc02e3f929d9a9235fd25b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 179 | 214 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 180 | 214 | 8 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 180 | 214 | 8 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.78e-06 | 181 | 214 | 8 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.78e-06 | 181 | 214 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 184 | 214 | 8 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 214 | 8 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.26e-06 | 185 | 214 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.26e-06 | 185 | 214 | 8 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 3.26e-06 | 185 | 214 | 8 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 186 | 214 | 8 | 72f7427d62d65e37bb0bf99229a1b75df081a128 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.40e-06 | 186 | 214 | 8 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.40e-06 | 186 | 214 | 8 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-06 | 187 | 214 | 8 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.53e-06 | 187 | 214 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-06 | 187 | 214 | 8 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.53e-06 | 187 | 214 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell-(011)_pDC|(01)_Dendritic_cell / immune cells in Peripheral Blood (logTPM normalization) | 3.53e-06 | 187 | 214 | 8 | 068502efa3f0ac4cea2fa4a18d1c2f686a4fba54 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.53e-06 | 187 | 214 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-06 | 187 | 214 | 8 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 3.53e-06 | 187 | 214 | 8 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 188 | 214 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 188 | 214 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 188 | 214 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 188 | 214 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.68e-06 | 188 | 214 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-06 | 189 | 214 | 8 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.82e-06 | 189 | 214 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-06 | 189 | 214 | 8 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-06 | 189 | 214 | 8 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| Drug | Z-Phe-OMC | 4.60e-07 | 8 | 208 | 4 | CID000127395 | |
| Drug | BOC-Ala-OMC | 4.60e-07 | 8 | 208 | 4 | CID000132159 | |
| Drug | aMMP | 1.10e-06 | 21 | 208 | 5 | CID000451880 | |
| Drug | Benzoyl-dl-leucine | 2.99e-06 | 4 | 208 | 3 | CID000294887 | |
| Drug | G2505_sigma | 2.99e-06 | 4 | 208 | 3 | CID000111098 | |
| Drug | allysine aldol | 7.41e-06 | 5 | 208 | 3 | CID000191270 | |
| Drug | Llvy-mca | 1.58e-05 | 35 | 208 | 5 | CID000121886 | |
| Drug | Es 8891 | 2.56e-05 | 7 | 208 | 3 | CID000195623 | |
| Drug | Ym 21095 | 2.56e-05 | 7 | 208 | 3 | CID000128978 | |
| Drug | Z-Phe-OH | 2.56e-05 | 7 | 208 | 3 | CID000070878 | |
| Drug | Zlll-mca | 2.56e-05 | 7 | 208 | 3 | CID000132936 | |
| Drug | Grgdspk | 3.59e-05 | 21 | 208 | 4 | CID000130667 | |
| Drug | AcPheOEt | 4.07e-05 | 8 | 208 | 3 | CID000094229 | |
| Drug | ATNE | 4.07e-05 | 8 | 208 | 3 | CID000130551 | |
| Drug | T.E.E | 4.07e-05 | 8 | 208 | 3 | CID000061327 | |
| Drug | Raloxifene Hydrochloride | MYC PDGFRB ADGRB2 RRM1 ARID5A AURKA AEBP1 LIPH AHR DYRK2 KPNB1 VWF ANK3 LAMC1 FAM171B SLC1A2 TFAP2A HMCN1 TMPO GREB1 PALLD | 4.14e-05 | 857 | 208 | 21 | ctd:D020849 |
| Drug | fulvestrant | MYC RRM1 AURKA F11R AHR HSP90AA1 DYRK2 KPNB1 SLC1A2 TFAP2A NCOR1 TMPO GREB1 CTSD TP53 | 4.18e-05 | 484 | 208 | 15 | ctd:C070081 |
| Drug | octylmethoxycinnamate | 4.29e-05 | 139 | 208 | 8 | ctd:C118580 | |
| Drug | A 80987 | 6.06e-05 | 9 | 208 | 3 | CID000461207 | |
| Drug | Suphepa | 6.06e-05 | 9 | 208 | 3 | CID000102818 | |
| Drug | 3-doxylandrostanol | 6.06e-05 | 9 | 208 | 3 | CID000189075 | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 7.13e-05 | 192 | 208 | 9 | 5990_DN | |
| Drug | BOCPheONP | 8.31e-05 | 2 | 208 | 2 | CID000111308 | |
| Drug | MPM-06 | 8.31e-05 | 2 | 208 | 2 | CID000161546 | |
| Drug | NSC-374899 | 8.31e-05 | 2 | 208 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 8.31e-05 | 2 | 208 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 8.31e-05 | 2 | 208 | 2 | CID004418081 | |
| Drug | c189 | 8.31e-05 | 2 | 208 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 8.31e-05 | 2 | 208 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 8.31e-05 | 2 | 208 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 8.31e-05 | 2 | 208 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 8.31e-05 | 2 | 208 | 2 | CID000074924 | |
| Drug | p-toluamidine | 8.31e-05 | 2 | 208 | 2 | CID000122753 | |
| Drug | 3-(4-dimethylamino-benzylidenyl)-2-indolinone | 8.31e-05 | 2 | 208 | 2 | ctd:C117011 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 8.31e-05 | 2 | 208 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 8.31e-05 | 2 | 208 | 2 | CID000011607 | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.35e-05 | 196 | 208 | 9 | 6772_DN | |
| Drug | Topo | 8.45e-05 | 153 | 208 | 8 | CID000065577 | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 9.38e-05 | 199 | 208 | 9 | 3239_UP | |
| Drug | butylparaben | 1.01e-04 | 157 | 208 | 8 | ctd:C038091 | |
| Disease | Polydactyly | 1.46e-06 | 117 | 201 | 8 | C0152427 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 4.64e-06 | 17 | 201 | 4 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 1.87e-05 | 216 | 201 | 9 | EFO_0007925, EFO_0007927 | |
| Disease | renal cell carcinoma (is_marker_for) | 2.89e-05 | 128 | 201 | 7 | DOID:4450 (is_marker_for) | |
| Disease | biological sex | 3.06e-05 | 230 | 201 | 9 | PATO_0000047 | |
| Disease | level of chymotrypsinogen B2 in blood serum | 4.62e-05 | 2 | 201 | 2 | OBA_2041192 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.77e-05 | 58 | 201 | 5 | C0002736 | |
| Disease | Colorectal Carcinoma | MYC OBSCN AURKA NELL1 GLI3 PHIP UNC13B DNAH3 LAMB3 LAMC1 ITPRID1 SETBP1 LGR6 TP53 FBXW7 | 1.02e-04 | 702 | 201 | 15 | C0009402 |
| Disease | chymotrypsinogen B measurement | 1.38e-04 | 3 | 201 | 2 | EFO_0801477 | |
| Disease | pancreatitis (biomarker_via_orthology) | 1.43e-04 | 39 | 201 | 4 | DOID:4989 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | MAGEA4 BCORL1 OBSCN AURKA AHR FGFR1 DLEC1 HSP90AA1 NPBWR1 VWF TFAP2D TECTA TFAP2A NCOR1 SETBP1 ROBO1 LGR6 TP53 FBXW7 | 1.49e-04 | 1074 | 201 | 19 | C0006142 |
| Disease | late-onset Alzheimers disease | 1.89e-04 | 292 | 201 | 9 | EFO_1001870 | |
| Disease | Hemangiosarcoma | 2.36e-04 | 18 | 201 | 3 | C0018923 | |
| Disease | angiosarcoma (is_implicated_in) | 2.75e-04 | 4 | 201 | 2 | DOID:0001816 (is_implicated_in) | |
| Disease | alcohol consumption measurement | RELN MDGA2 WDR76 PTPRB NRXN1 PTPRJ GLI3 IZUMO1 WDR90 SVOP TFAP2D AFF3 SGPP2 GRM3 SEZ6L2 INTS5 SPHKAP SETBP1 IGSF9B CSMD1 | 3.41e-04 | 1242 | 201 | 20 | EFO_0007878 |
| Disease | cortical surface area measurement | THSD4 TANC2 PRTG INTU RELN ATG13 NELL1 NEO1 GLI3 FGFR1 ARHGAP21 ANK3 ARHGEF12 LAMC1 ATP13A2 NCOR1 NPRL2 FSHR ROBO1 CALCRL PDZRN3 | 3.64e-04 | 1345 | 201 | 21 | EFO_0010736 |
| Disease | neuroimaging measurement | THSD4 PRTG RELN NELL1 NEO1 GLI3 GDF5-AS1 ANK3 AFF3 ARHGEF12 LAMC1 ATP13A2 NCOR1 FSHR ROBO1 CALCRL RAPGEF2 PDZRN3 | 4.04e-04 | 1069 | 201 | 18 | EFO_0004346 |
| Disease | 2-hydroxyoctanoate measurement | 4.56e-04 | 5 | 201 | 2 | EFO_0800192 | |
| Disease | 2-hydroxysebacate measurement | 4.56e-04 | 5 | 201 | 2 | EFO_0800571 | |
| Disease | parental longevity | SNPH ADGRB2 NELL1 PHIP BICRA LAMC1 FANK1 SETBP1 HACL1 KRTAP11-1 CSMD1 | 6.16e-04 | 494 | 201 | 11 | EFO_0007796 |
| Disease | Hypertrophic Cardiomyopathy | 6.22e-04 | 57 | 201 | 4 | C0007194 | |
| Disease | cortical thickness | THSD4 PRTG INTU RELN NELL1 NEO1 GLI3 FGFR1 DLEC1 ARHGAP21 GDF5-AS1 ARHGEF12 LAMC1 ATP13A2 NPRL2 FSHR ROBO1 CALCRL | 6.46e-04 | 1113 | 201 | 18 | EFO_0004840 |
| Disease | pancreatic cancer (is_marker_for) | 6.51e-04 | 101 | 201 | 5 | DOID:1793 (is_marker_for) | |
| Disease | Weight Gain | 6.81e-04 | 102 | 201 | 5 | C0043094 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 7.56e-04 | 60 | 201 | 4 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | Liver carcinoma | MYC GPR182 RRM1 WDR76 AURKA KIF2C ROBO1 SLC25A47 CSMD1 CTSD TP53 | 7.62e-04 | 507 | 201 | 11 | C2239176 |
| Disease | FEV/FEC ratio | THSD4 CTRB2 CHRM3 FCGBP FGFR1 DLEC1 FRAS1 ARHGEF28 PILRA HCN1 AFF3 FAM171B ATP13A2 SLC1A2 HMCN1 IL1RL1 CSMD1 CTRB1 PDZRN3 | 7.77e-04 | 1228 | 201 | 19 | EFO_0004713 |
| Disease | Colorectal cancer | 8.07e-04 | 27 | 201 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 8.07e-04 | 27 | 201 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 8.07e-04 | 27 | 201 | 3 | cv:C0009404 | |
| Disease | amino acid measurement | TANC2 SETX CHRM3 PTPRB PTPRJ OR1P1 SUSD4 VWF ARHGEF28 COG7 PELP1 CSMD1 MUC2 | 8.16e-04 | 678 | 201 | 13 | EFO_0005134 |
| Disease | Pigmented Basal Cell Carcinoma | 9.00e-04 | 28 | 201 | 3 | C1368275 | |
| Disease | cholangiocarcinoma (is_marker_for) | 9.65e-04 | 64 | 201 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Carcinoma, Basal Cell | 9.99e-04 | 29 | 201 | 3 | C4721806 | |
| Disease | severe acute respiratory syndrome, COVID-19 | THSD4 RELN USP9X CCDC85A NRXN1 ARHGEF28 SGPP2 ADAMTS12 EIF2AK1 CSMD1 | 1.05e-03 | 447 | 201 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | QRS duration | 1.05e-03 | 298 | 201 | 8 | EFO_0005055 | |
| Disease | body weight | RELN MDGA2 NELL1 NRXN1 PTPRJ NADK KPNB1 UNC13B TFAP2D ARHGEF12 POM121L2 CEP192 MON1A HUWE1 CDH19 NCOR1 SPHKAP SETBP1 TP53 | 1.06e-03 | 1261 | 201 | 19 | EFO_0004338 |
| Disease | factor XI measurement, venous thromboembolism | 1.10e-03 | 30 | 201 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.21e-03 | 68 | 201 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_marker_for) | 1.26e-03 | 8 | 201 | 2 | DOID:2513 (is_marker_for) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.26e-03 | 8 | 201 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Leukemia, Megakaryoblastic, of Down Syndrome | 1.26e-03 | 8 | 201 | 2 | C1860789 | |
| Disease | 2-aminooctanoate measurement | 1.26e-03 | 8 | 201 | 2 | EFO_0800349 | |
| Disease | sarcoma (is_implicated_in) | 1.26e-03 | 8 | 201 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | factor VIII measurement, venous thromboembolism | 1.59e-03 | 34 | 201 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 1.61e-03 | 9 | 201 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.61e-03 | 9 | 201 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.61e-03 | 9 | 201 | 2 | EFO_0009824 | |
| Disease | Pancreatic carcinoma, familial | 1.61e-03 | 9 | 201 | 2 | C2931038 | |
| Disease | breast carcinoma | MCM8 RNF145 PHIP ARHGEF28 HCN1 LMTK2 ARHGEF12 POM121L2 LAMC1 CEP192 GRM3 SETBP1 CDYL2 GREB1 LGR6 TP53 | 1.74e-03 | 1019 | 201 | 16 | EFO_0000305 |
| Disease | Malignant Neoplasms | 1.88e-03 | 128 | 201 | 5 | C0006826 | |
| Disease | waist-hip ratio | THSD4 TMEM165 NELL1 GLI3 FGFR1 DLEC1 PHIP ARHGAP21 DMXL2 TFAP2D ANK3 AFF3 CEP192 ATP13A2 SETBP1 CDYL2 ROBO1 CALCRL | 1.90e-03 | 1226 | 201 | 18 | EFO_0004343 |
| Disease | Disproportionate short stature | 1.92e-03 | 77 | 201 | 4 | C0878659 | |
| Disease | response to carboplatin, response to antineoplastic agent | 2.00e-03 | 10 | 201 | 2 | GO_0097327, GO_0097328 | |
| Disease | 2-ketocaprylate measurement | 2.00e-03 | 10 | 201 | 2 | EFO_0800110 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.00e-03 | 10 | 201 | 2 | EFO_1000650, HP_0000131 | |
| Disease | Head and Neck Carcinoma | 2.00e-03 | 10 | 201 | 2 | C3887461 | |
| Disease | glucagon-like peptide-1 measurement | 2.00e-03 | 10 | 201 | 2 | EFO_0008465 | |
| Disease | phosphatidylcholine 32:1 measurement | 2.20e-03 | 38 | 201 | 3 | EFO_0010373 | |
| Disease | venous thromboembolism, factor VII measurement | 2.20e-03 | 38 | 201 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | Cleft upper lip | 2.38e-03 | 39 | 201 | 3 | C0008924 | |
| Disease | Semantic-Pragmatic Disorder | 2.44e-03 | 11 | 201 | 2 | C0454655 | |
| Disease | Ductal Carcinoma | 2.44e-03 | 11 | 201 | 2 | C1176475 | |
| Disease | pulmonary fibrosis | 2.44e-03 | 11 | 201 | 2 | EFO_0009448 | |
| Disease | nucleus accumbens volume change measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0021493 | |
| Disease | sleep disorder (implicated_via_orthology) | 2.44e-03 | 11 | 201 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Auditory Processing Disorder, Central | 2.44e-03 | 11 | 201 | 2 | C0751257 | |
| Disease | Language Delay | 2.44e-03 | 11 | 201 | 2 | C0023012 | |
| Disease | Language Development Disorders | 2.44e-03 | 11 | 201 | 2 | C0023014 | |
| Disease | trypsin-2 measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0008305 | |
| Disease | X-18913 measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0800795 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | Speech Delay | 2.44e-03 | 11 | 201 | 2 | C0241210 | |
| Disease | uterine fibroid | 2.50e-03 | 199 | 201 | 6 | EFO_0000731 | |
| Disease | Giant Cell Glioblastoma | 2.64e-03 | 84 | 201 | 4 | C0334588 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.74e-03 | 41 | 201 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.74e-03 | 41 | 201 | 3 | C0858252 | |
| Disease | basal cell carcinoma (is_implicated_in) | 2.91e-03 | 12 | 201 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | N-acetyl-2-aminooctanoate measurement | 2.91e-03 | 12 | 201 | 2 | EFO_0800567 | |
| Disease | Myeloproliferative disease | 2.91e-03 | 12 | 201 | 2 | C0027022 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.94e-03 | 42 | 201 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | Schizophrenia | ARHGAP32 RELN PDGFRB NRXN1 FGFR1 ANK3 GRM3 LARS2 SLC1A2 ADAMTS12 NPRL2 CSMD1 CTRL TP53 | 3.06e-03 | 883 | 201 | 14 | C0036341 |
| Disease | schizophrenia (is_marker_for) | 3.36e-03 | 44 | 201 | 3 | DOID:5419 (is_marker_for) | |
| Disease | cognitive impairment measurement | 3.36e-03 | 44 | 201 | 3 | EFO_0007998 | |
| Disease | Mammary Carcinoma, Human | AURKA AHR FGFR1 HSP90AA1 TFAP2A NCOR1 SETBP1 LGR6 TP53 FBXW7 | 3.37e-03 | 525 | 201 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | AURKA AHR FGFR1 HSP90AA1 TFAP2A NCOR1 SETBP1 LGR6 TP53 FBXW7 | 3.37e-03 | 525 | 201 | 10 | C1257931 |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.38e-03 | 90 | 201 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | cleft lip | 3.46e-03 | 284 | 201 | 7 | EFO_0003959 | |
| Disease | Mammary Neoplasms | AURKA AHR FGFR1 HSP90AA1 TFAP2A NCOR1 SETBP1 LGR6 TP53 FBXW7 | 3.46e-03 | 527 | 201 | 10 | C1458155 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.51e-03 | 148 | 201 | 5 | C0279702 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.59e-03 | 286 | 201 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | albuminuria | 3.95e-03 | 94 | 201 | 4 | EFO_0004285 | |
| Disease | asymmetric dimethylarginine measurement | 3.98e-03 | 14 | 201 | 2 | EFO_0010463 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 3.98e-03 | 14 | 201 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Adenocarcinoma Of Esophagus | 3.98e-03 | 14 | 201 | 2 | C0279628 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 3.98e-03 | 14 | 201 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | vascular dementia (biomarker_via_orthology) | 3.98e-03 | 14 | 201 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | AURKA AHR FGFR1 HSP90AA1 TFAP2A NCOR1 SETBP1 LGR6 TP53 FBXW7 | 4.00e-03 | 538 | 201 | 10 | C0678222 |
| Disease | Gastrointestinal Stromal Sarcoma | 4.05e-03 | 47 | 201 | 3 | C3179349 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 4.30e-03 | 48 | 201 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAIITPQTCYAGAVS | 756 | P35869 | |
| VRTRSCVSSPYGTLC | 331 | O60241 | |
| ETSVHCTSYRGVPAS | 256 | P51826 | |
| CLPGYVRSHSTQTLT | 81 | P04003 | |
| SLCSPSRSAFLTGRY | 76 | P54793 | |
| RTCSTTTPAVYARVA | 236 | Q6GPI1 | |
| AQYTTRISPVCLASS | 131 | P40313 | |
| SPGSTSAATCTRRHY | 121 | Q03989 | |
| VGTPVGTITLSCAYR | 176 | O75143 | |
| GTAVCATNRRSFPTY | 71 | P05156 | |
| LCISLSSSAYTAVPA | 66 | Q9N2K0 | |
| TAGKYLSDSCSPRSL | 496 | P83436 | |
| QYPSRSSGLTAICTF | 151 | Q9NVV5 | |
| APSSRRTTLCGTLDY | 281 | O14965 | |
| IRSTVTFSCDPGYTL | 891 | Q96PZ7 | |
| SLADTRATSVCISPY | 2856 | Q68DQ2 | |
| RATSVCISPYSGKNT | 2861 | Q68DQ2 | |
| CPTITRTYSLGKSSR | 581 | Q8IUX7 | |
| SSASTYVPTVCNGRE | 856 | Q14832 | |
| VHPTGSSRSCSSYEL | 281 | P20309 | |
| VTSCLGSTSSPFVIF | 676 | Q5H9F3 | |
| GTVSAYCSLNLPGST | 46 | A6NJG6 | |
| FCSVPGRLSLLSSTS | 211 | P05549 | |
| PVSTISCSYESASRS | 241 | Q01518 | |
| SGIIRASSESSYPTA | 291 | Q53GS7 | |
| SAGHLSSSSIYPVCL | 996 | Q8TDJ6 | |
| SIVGRPVAVSCSYTG | 1066 | Q8TDJ6 | |
| PVAVSCSYTGRLAVA | 1071 | Q8TDJ6 | |
| TSSCVCPGYITVVSV | 326 | Q6ZW61 | |
| VDPYLLGTSSIDTTC | 131 | P61962 | |
| LSSRYLISTGSTSQP | 1076 | P58397 | |
| GSSSYVTGAACISPV | 251 | Q6UXT9 | |
| RTGTGDIATCYSPRT | 1316 | Q9NZN5 | |
| FCSVPGRLSLLSSTS | 211 | Q7Z6R9 | |
| STASRAISDICFPTY | 141 | Q6P387 | |
| GLTSPRYTSTLGTAT | 1656 | Q9HC84 | |
| DPREACGSSSYVASI | 466 | P0DJD3 | |
| DPREACGSSSYVASI | 466 | P0DJD4 | |
| DPREACGSSSYVASI | 466 | P0C7P1 | |
| DPREACGSSSYVASI | 466 | A6NEQ0 | |
| SAYNTGESCRSTPLT | 756 | Q9UPQ7 | |
| AASAIGYLTSRPGVC | 66 | Q9UJ83 | |
| GVRSRSYSCSSPKIS | 551 | Q8N1W1 | |
| LLYTALRCSAPSSEG | 716 | Q9UN72 | |
| PSCSSLYTDITVLRT | 266 | Q9C0D6 | |
| TSVGPLYSGCRLTSL | 12431 | Q8WXI7 | |
| NTSVGPLYSGCRLTL | 12741 | Q8WXI7 | |
| NTSVGPLYSGCRLTL | 13521 | Q8WXI7 | |
| KSTSVGPLYSGCRLT | 13676 | Q8WXI7 | |
| LIYSSDTLGAALCPT | 56 | P23467 | |
| ECSFSSLTPGRLYTV | 696 | P23467 | |
| CNITGLRPATSYVFS | 171 | Q12913 | |
| IPGLRSSTFYNITVC | 421 | Q12913 | |
| GDASSIVSAICYTVP | 2696 | Q86XX4 | |
| SAYLSSRRSSGISPC | 856 | P10071 | |
| LSQGSLLESPSYTVC | 51 | Q96LI6 | |
| DPASNTYTLVTCLGL | 171 | P43358 | |
| ARSYGSLVQSACSPV | 21 | Q96S90 | |
| CTSASLEPSYVLRAI | 381 | Q9Y697 | |
| APRGVYVCGNTTTTS | 471 | Q9UJA3 | |
| LPCTYHTSTSSREGL | 41 | Q99795 | |
| SLDVSGTPVCTSYNL | 641 | Q4ZG55 | |
| TPILSRGTSFNSCYS | 111 | Q6ZRS4 | |
| VSCVRAYGKSPSLGS | 671 | Q9HBX8 | |
| DTCSSRYPVSLSSDL | 351 | P31152 | |
| RLVSSPCCIVTSTYG | 456 | Q58FF7 | |
| PIITVTAAHSGTYRC | 166 | Q9HCN6 | |
| RHGDSISITTSCYPL | 391 | O95544 | |
| VSVFLSSCSSVYLRP | 246 | Q8NHC7 | |
| ICVTVSLRSYGTIFP | 146 | Q8NGK2 | |
| STVPVTTEVSYAGCT | 5076 | Q02817 | |
| RGVPYASCTATQSFS | 1681 | Q14999 | |
| TRTGGISYIPTLSSF | 196 | Q8IV20 | |
| GSPYLSRCINSESST | 1396 | Q8IWU2 | |
| YEASTPTGISASCRR | 351 | P42167 | |
| SLSPVARSFSACSVG | 41 | Q92764 | |
| LSSLRESCTITAYPC | 256 | Q8WWY8 | |
| LSTSSSSCIIAGYPN | 41 | P50222 | |
| GVVRLSSYSSPTLQS | 356 | Q9UQ07 | |
| SGTAKSVTCTYSPAL | 116 | P04637 | |
| SGTISVNTLRTPYTA | 586 | Q9ULB1 | |
| SGYRRPTSSALDCVL | 26 | Q6TCH4 | |
| QGEVLGSSPYTSSRC | 561 | Q8IZL8 | |
| PCSRVEYVSSLSSSV | 1551 | A7KAX9 | |
| PKLSSIIDCTGTASY | 341 | Q7Z6Z7 | |
| KQYIRSCPGTASTAA | 556 | C9JSJ3 | |
| TCLDSYGVSRLSGSV | 766 | Q92832 | |
| TIPAITSDDAGTYSC | 296 | Q7Z553 | |
| TFSGPSCLSYRVGTK | 231 | Q8TDS5 | |
| SCLSYRVGTKPSASL | 236 | Q8TDS5 | |
| GSCRFSYSDPSIIVL | 271 | P78509 | |
| LVILICFSASTPGYS | 36 | Q04941 | |
| CFSASTPGYSSLSVI | 41 | Q04941 | |
| VEDTGRYTCLASSPA | 3591 | Q96RW7 | |
| RICYSVSLSLGEPTT | 36 | Q8NH94 | |
| SGTLGRAYTSTSVPI | 636 | Q86XN7 | |
| RAYTSTSVPISLSAC | 641 | Q86XN7 | |
| VYVCRATTPGTRNFT | 301 | Q2VWP7 | |
| VATSPTCRRTLFGDY | 686 | Q9ULD6 | |
| VISYLSLTCSSPFAG | 6651 | Q5VST9 | |
| RYTCLATNPSGSDTT | 341 | Q8WX93 | |
| CYSPLGTKASAVSAI | 616 | Q86VX9 | |
| GIVYASLALSSSTSP | 266 | Q9UKJ1 | |
| VVTTCSGILSYPFDT | 231 | Q9H0C2 | |
| DPLSSSVSSVRLSGY | 26 | Q9NQ11 | |
| SAILSPCSYTTAVCS | 691 | O60741 | |
| TCIVRSPTFNRTGYA | 86 | Q01638 | |
| PLYRVAGTAVSISCN | 36 | Q969P0 | |
| GSIAPGLSVTYSCES | 171 | P20023 | |
| VCPVYKTSARRGTLS | 4066 | Q8TD57 | |
| THTSRVGTCLYASPE | 486 | Q9BQI3 | |
| SLCPSTSLLYLGRTE | 146 | O75460 | |
| ATLGPLSSSTTYTVR | 611 | Q9P218 | |
| SVPADSGLYACVTSS | 91 | P11362 | |
| YATAADCGRTVLSPV | 426 | Q9Y6R7 | |
| GATTSPGVYELSSRC | 5251 | Q9Y6R7 | |
| PQISPCSSTRSLTSY | 601 | Q96MT8 | |
| RRPLTSCTIFLGYTS | 91 | P49366 | |
| TASSAGTLPVTFRCL | 361 | P43004 | |
| SLSGYLSQDTVSVPC | 146 | P07339 | |
| GYRLIGSSSATCIIS | 126 | Q2VPA4 | |
| SEYTSTTGLVPCSAT | 191 | Q969H0 | |
| NTYLCFLTTGPRSSR | 196 | Q5U4N7 | |
| SSFTKSCYPRGTLSQ | 26 | Q9NPH9 | |
| SLRTPSASALYTSLG | 1791 | Q12955 | |
| ASLCQLTASTAPYVR | 191 | Q96PX6 | |
| LPSGCSLSYRTISCI | 316 | O94769 | |
| ATARCSAILLPTTAY | 296 | Q96NU7 | |
| TETYRPSSASQCVAG | 101 | Q14974 | |
| VCSPAGVSRLTYVSE | 1031 | Q8TEP8 | |
| LRASSTCGLTKPETY | 41 | Q13751 | |
| CSTTYSRPLTFVSSG | 96 | Q8IUC1 | |
| TSVLCRPISYSISSC | 131 | P59991 | |
| PSSLVYSTALCSPST | 26 | Q3LI77 | |
| SPVGSLSTQCDSYGR | 401 | P11047 | |
| RYGTSPCSSAVTRTS | 376 | O14640 | |
| PAVYSTDLLGVCSLT | 1201 | Q86VF2 | |
| YRCELGSVNSSPATI | 231 | Q8IYV9 | |
| GSRYVLTSPRSLEAC | 86 | Q9NQR7 | |
| AYLSTCPGQSSSLAV | 171 | Q96AY2 | |
| RLVTSPCCIVTSTYG | 591 | P07900 | |
| HCSSAPRVTNGSTYI | 671 | P23945 | |
| CTTRTKTGVGYPQLS | 186 | P36959 | |
| YVSSSRSLGLPIAAS | 1201 | Q9NZM4 | |
| AAVGCPISSLRTTSY | 1236 | Q9Y238 | |
| TQRRASCSPLSYAGL | 126 | A6NEL3 | |
| PSSEASCAYVLIVTA | 31 | Q9UKG4 | |
| VSSKGYPRYCTVTTL | 456 | Q92630 | |
| SPGISSCEYTLNTLR | 566 | Q99661 | |
| YISICSLLGSFTVPS | 191 | Q7RTP0 | |
| LRSASYTVSTISDGP | 416 | Q16602 | |
| YRLTVSESAPTGTSI | 261 | Q9H159 | |
| DTCSTSSPGVYARVT | 236 | P17538 | |
| SRYSSSLLESVSVPG | 621 | Q6P995 | |
| DSRCSVAPGSVVEYS | 421 | O14772 | |
| VSSTFVLTCSGSAPV | 46 | P09619 | |
| GFAIPVSTICVLYTT | 211 | P48145 | |
| STATILNPRDTYCRG | 101 | Q8N323 | |
| SSILTSLTFTLPYCG | 156 | Q8NH80 | |
| SVNPGYCVSLTSSTG | 131 | P05451 | |
| VKLSCAYSGFSSPRV | 46 | Q9Y624 | |
| TFIATPGSSSSLCIV | 521 | Q9GZY0 | |
| GTVIRAYLCPSSSSS | 266 | Q8NH06 | |
| SGECEYSPLVSVSTT | 91 | Q8TC84 | |
| TGRTFYLQLCPSSDT | 146 | Q8TC56 | |
| RSQSYIPTSGCRAST | 181 | Q9HB19 | |
| IYNGTRPCESVSSSV | 186 | Q93008 | |
| SVSVGSSLLPSCYST | 421 | Q2M3C7 | |
| VYPTATRALGLGTCS | 451 | Q8N4V2 | |
| CVSGPSADSVYTKVR | 16 | Q5T2D2 | |
| ATGSSPGITLTTYSR | 531 | Q86VL8 | |
| PGITLTTYSRSECHV | 536 | Q86VL8 | |
| RVIPGCTRSIYSATG | 31 | Q15031 | |
| PSSISAGCLGLSLRY | 56 | Q86VH5 | |
| RSYSTPSGCLELTDS | 511 | P0DPF2 | |
| SLDRSYSTPSGCLEL | 996 | P0DPF2 | |
| LDRSYSTPSGCLELT | 1241 | P0DPF2 | |
| RSYSTPSGCLELTDS | 1731 | P0DPF2 | |
| RSYSTPSGCLELTDS | 2951 | P0DPF2 | |
| SLDRSYSTPSGCLEL | 3436 | P0DPF2 | |
| VLQESLDRCYSTPSG | 441 | B4DH59 | |
| VLQESLDRCYSTPSG | 516 | B4DH59 | |
| VLQESLDRCYSTPSG | 591 | B4DH59 | |
| LSPSRRSGLCSPSYV | 61 | P01106 | |
| EGPSAQSTISRYACR | 176 | Q8N2H9 | |
| CLSVDRYVTLTSASP | 146 | O15218 | |
| RSVQCLYTSSAFPSG | 1876 | O75376 | |
| RGSSVILNCSAYSEP | 66 | Q92859 | |
| SSNYLSCRTTPAIVP | 1256 | Q7Z333 | |
| CTVSLVSSVSFGTYR | 61 | Q6Q0C1 | |
| DCSYGAVTSPTSTLE | 161 | Q9HCD6 | |
| SPVSRTLGLLDCTYS | 191 | Q6UXD5 | |
| GSSFPGTIISRVLSC | 231 | Q6P9B9 | |
| VFQLYCSLSPGTTVR | 281 | Q8WTW4 | |
| RSSTYTKLSDPAVCG | 211 | O15079 | |
| TPVSRAAPCYSLASR | 171 | Q8IXM7 | |
| LTTSCGSLAYSAPEI | 171 | Q9NRH2 | |
| YSVPSTCDTFLLGTA | 656 | Q96KW2 | |
| VVYFGPLTCSIITTT | 261 | P78383 | |
| VTYTSVGICATTFVP | 376 | Q8IWX5 | |
| RCKATGEAVYTVPSS | 211 | Q96AP0 | |
| APLTYISLVGCSISI | 246 | Q8IZF4 | |
| TPYATIRLTPAGCSS | 381 | Q8N8U2 | |
| SISQTCTSYGPALGA | 26 | Q5K130 | |
| TLSRVSPGSLYTCRT | 16 | P37287 | |
| SPGSLYTCRTRTHNI | 21 | P37287 | |
| SISVPGSYINSTCGL | 446 | O75443 | |
| GRGLYATATVISSPS | 1211 | Q9Y4G8 | |
| SVSEGTPVLLRCNYS | 31 | A0A0B4J237 | |
| ESACTTVPGVSLYSS | 951 | Q5W0Q7 | |
| TRNSGAPRTTYLASC | 1066 | Q96KV7 | |
| STVSCPLGYLASTAT | 2401 | P04275 | |
| SPLCSGSKRYLSSTG | 276 | Q8WWQ0 | |
| AVSCIRATGSYIAGT | 251 | P23921 | |
| YTCVPSNSLGRSPSA | 301 | Q9UPX0 | |
| SSSRVTAVIPCFPYA | 81 | P11908 | |
| LQTSFPVGTVISYRC | 196 | Q5VX71 | |
| VSPSEYTAACSRLLV | 61 | Q9UK41 | |
| SGQSTSPLVIDYTCR | 6 | Q8NCL8 | |
| VRAQLTSTGPTCYSL | 241 | A0A1W2PR48 | |
| STVAEACLPATSYLL | 141 | Q96DC7 | |
| TNSFSPVCRSYGITS | 141 | Q9H3T2 | |
| RAISPTSSSRYGSSC | 251 | O14795 | |
| GRYTCIASTPSGEAT | 521 | Q9Y6N7 | |
| TCLSVLFGYATTVIP | 141 | Q9HC07 | |
| RCSPISGHTSVSSYQ | 41 | A0A0A0MS05 | |
| NVCLGSVLPYGATST | 76 | Q99835 | |
| STTTTTYQGSLCPRQ | 371 | Q6ZN44 | |
| TDCGRRFTYPSLLVS | 186 | P0C7X2 | |
| AYFSPLTGNRVVTTC | 501 | Q9H967 | |
| SPESLNYCTTSGLVT | 196 | Q16401 | |
| SSTCGQIASYPLALV | 386 | Q9BV35 | |
| SQPARSTAISCIGAY | 281 | Q6ZMP0 | |
| TVFSFCLPGSVRSSS | 116 | Q6NUS6 | |
| PLGKTAELTCTYSTS | 36 | Q96IQ7 | |
| NLSLTSSGTYRCVAT | 206 | Q96IQ7 | |
| YCPRSASQGALTSPS | 471 | Q5T5U3 | |
| CSTPYSLLGLVFTVS | 271 | Q96MT1 | |
| LSSEPVDSCTKRYSG | 1251 | Q9Y6X0 | |
| TSCVSGYALGLTASL | 21 | Q5TIE3 |